CVS Health (CVS) fundamentals: P/E, valuation, undervalued?
CVS Health · Health Care · ref. ETF XLV · price $87.55
In short — CVS Health trades at 23.1× earnings (P/E), 10.3× forward, with a net margin of 1.2 % and revenue growth of +7 %. Read: Cheap for the growth (P/E 10 for ~189% growth (PEG 0.1)).
Is CVS Health stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$87.55+9.9% over range
Oct 14, 25low $70.08 · high $110.6Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 15 analysts
Valuation : Cheap for the growth — P/E 10 for ~189% growth (PEG 0.1)
Valuation
23.1
P/E (price/earnings)
10.3
Forward P/E
0.12
PEG
1.4
Price/book (P/B)
$112.0B
Market cap
3.79
EPS
Profitability & growth
1.2 %
Net margin
+7 %
Revenue growth
+189 %
Earnings growth
$76.3B
Total debt
CVS Health income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $322.5B | $4.1B | 1.3 % |
| 2023 | $357.8B | $8.3B | 2.3 % |
| 2024 | $372.8B | $4.6B | 1.2 % |
| 2025 | $402.1B | $1.8B | 0.4 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is CVS Health's P/E and is the stock undervalued? What's a good P/E?
CVS Health's P/E is 23.1 (forward 10.3). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Cheap for the growth".
Is CVS Health profitable?
CVS Health has a net margin of 1.2 % (EPS 3.79). The company is profitable.
Is CVS stock expensive?
Our read: "Cheap for the growth" — P/E 10 for ~189% growth (PEG 0.1). Cross-check with growth and sector.
💬 A question about CVS Health? The JPI assistant answers using our backtest data.